Advancing Global Health
Issued by Bureau of Global Health Security and Diplomacy · via Grants.gov — US federal funding opportunities
- Published
- 21 Sept 2026
- Closes
- 14 Feb 2027, 23:59 UTC
- Value
- USD 2,147,483,647
- Reference
- DFOP0017890
- Location
- United States
- Sector
- Healthcare & Pharma
Details
The Department of State invites eligible applicants to advance the America First Global Health Strategy, which aims to save lives, strengthen health systems, enhance efficiency, foster self-reliance, and ensure U.S. investments benefit American safety, strength, and prosperity. This Annual Program Statement (APS) establishes a supplemental framework through which the Department of State may identify and support projects that complement, extend, and/or fill identified gaps in the implementation of these bilateral MOUs. Through specific Addenda, the Department will signal priorities and needs. This APS provides the standard application instructions for the submission of all Statements of Interest (SOIs) to these specific Addenda. GHSD will collaborate with Embassies and other Department of State Bureaus and Offices to post specific funding opportunities through Addenda to this APS that address health challenges and priorities of importance.
Eligibility: Please see APS instructions for eligibility criteria
Estimated total programme funding: USD 2147483647
Award range: USD 500000 – 250000000
Expected number of awards: 100
CFDA number(s): 19.029
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
There are 399 open Healthcare & Pharma tenders in United States. This one closes in 143 days.
Similar Healthcare & Pharma tenders
- Breathing Apparatus — Safety and Rescue Equipment· closes 26 Oct
- Advancing bio-printing of living cells for regenerative medicine· closes 22 Sept
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals· closes 13 Apr
- Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential· closes 13 Apr
- Development of innovative antimicrobials against pathogens resistant to antimicrobials· closes 13 Apr
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Bryn Beryl and Dolgellau Hospitals X-Ray Room ReplacementsBetsi Cadwaladr University Health Board · United Kingdom
- UHB Immunology Managed ServiceUniversity Hospitals Birmingham NHS Foundation Trust · United Kingdom
- The Provision of Mental Health Support for children aged 5-18 years in Trafford.NHS Greater Manchester Integrated Care Board · United Kingdom
- WPL07209 - Provision of Ophthalmic Phacoemulsification, Vitrectomy, and Associated Surgical Equipment & ConsumablesUHS ESTATES LIMITED · United Kingdom
- Private Ambulance Service (PAS)East Midlands Ambulance Service NHS Trust · United Kingdom
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →